$Biofrontera (BFRI.US)$ - Biofrontera AG Enrolls First Patie...
$Biofrontera (BFRI.US)$ - Biofrontera AG Enrolls First Patient To Phase IIb Clinical Study Evaluating Ameluz / BF-RhodoLED For Acne. stock has support at $5.50
$QuantumScape (QS.US)$ - stock is near the support area of $22. If held we can see a reversal to $25 plus or more.
$Longeveron (LGVN.US)$ - stock in consolidation mode. On watch for a break of $20 to keep moving higher.
$Lucid Group (LCID.US)$ - stock bouncing off $35 support as expected. Stock looking bullish above $40
$Galera Therapeutics (GRTX.US)$ - Galera Announces Primary Endpoint Met Statistical Significance In Corrected Topline Efficacy Data Of Phase 3 ROMAN Trial Of Avasopasem. Also Hearing BTIG Upgrades To Buy, Sets $15 Price Target
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Michael Finnegan : there is alot of accunts from China. they seem like catfish accounts to get you to invest in crap
李白的李 Michael Finnegan : you are absolutely right
Mike Hunt : QS is on the launch pad
Mrrichierich : @Mikefinnegan it’s cause Moo moo is outta China lol